Start Your Healing Journey with Wellness Drip.
Low-dose ketamine infusions as a therapy for the treatment of depression are slowly starting to become a more mainstream concept. There have been several recent reports in the media profiling the type of client successes that we here at The Wellness Drip have seen regularly. Less well known is ketamine’s effectiveness in treating several pain syndromes, including migraine headaches.
During treatment, we go above and beyond to make sure all of our clients feel as comfortable as possible in their own private rooms. Total appointment time is generally about 2 hours, with infusions typically lasting 50-60 minutes.
Some people receiving low dose ketamine infusions describe experiencing a mild dissociative sensation – such as floating in outer space or the ocean, or feeling detached from their usual thoughts, awareness, or surroundings. Many clients find the experience to be calming or euphoric. Our clinical team monitors you closely throughout the infusion to help ensure you feel safe and supported.
These are all ordinary components of the treatment. You will always remain in a safe atmosphere with our team there to monitor you and be readily available during your infusion.
Ketamine has been used safely for decades as an anesthetic and analgesic. In recent years, low-dose ketamine has also been studied for its potential benefits in several conditions, including treatment-resistant depression and certain types of chronic pain and migraines.
If you are interested in learning more about how Ketamine Treatment for Migraines can help you, contact The Wellness Drip today and schedule your consultation.
Some hospital in-client services and hospital emergency rooms have employed Ketamine infusions for several years to treat intractable migraine headaches. Recently, Dr. Eric Schwenk, the Director of Orthopedic Anesthesia at Thomas Jefferson University Hospital in Philadelphia, PA, and colleagues completed a retrospective study to ascertain the effectiveness of ketamine in this population. All sixty-one clients studied received daily low dose ketamine infusions for three to seven consecutive days.
Almost 75 percent of the clients experienced an improvement in their migraine intensity. On a scale of 0 – 10, the average migraine headache pain rating at admission was 7.5, compared to 3.4 on discharge. The moderate infusion was 5.1 consecutive days. The infusion day with the lowest average pain rating was day 4.
This study’s focus was on short-term relief. The author is encouraged by the potential for ketamine infusions to provide long-term relief.
